{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T19:54:23Z","timestamp":1789847663921,"version":"4.0.1"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005888","name":"Medical University of Lodz internal funds","doi-asserted-by":"publisher","award":["503\/3-014-01\/503-31-001"],"award-info":[{"award-number":["503\/3-014-01\/503-31-001"]}],"id":[{"id":"10.13039\/501100005888","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005888","name":"Medical University of Lodz internal funds","doi-asserted-by":"publisher","award":["502-03\/3-014-01\/502-34-066"],"award-info":[{"award-number":["502-03\/3-014-01\/502-34-066"]}],"id":[{"id":"10.13039\/501100005888","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004040","name":"KU Leuven","doi-asserted-by":"publisher","award":["GOA 15\/19 TBA"],"award-info":[{"award-number":["GOA 15\/19 TBA"]}],"id":[{"id":"10.13039\/501100004040","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.ejmech.2016.10.002","type":"journal-article","created":{"date-parts":[[2016,10,8]],"date-time":"2016-10-08T06:58:08Z","timestamp":1475909888000},"page":"84-100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"C","title":["Synthesis, anti-varicella-zoster virus and anti-cytomegalovirus activity of quinazoline-2,4-diones containing isoxazolidine and phosphonate substructures"],"prefix":"10.1016","volume":"126","author":[{"given":"Dorota G.","family":"Piotrowska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graciela","family":"Andrei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Schols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Snoeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"\u0141ysakowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2016.10.002_bib1","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1056\/NEJM198312013092205","article-title":"Varicella and herpes zoster \u2013 changing concepts of the natural history, control, and importance of a Not-So-Benign Virus (First and second of two parts)","volume":"309","author":"Weller","year":"1983","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2016.10.002_bib2","doi-asserted-by":"crossref","first-page":"221","DOI":"10.7326\/0003-4819-108-2-221","article-title":"Varicella-zoster virus infections: biology, natural history, treatment and prevention","volume":"108","author":"Straus","year":"1988","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ejmech.2016.10.002_bib3","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ejmech.2015.04.053","article-title":"New efficient artemisinin derived agents against human leukemia cells, human cytomegalovirus and Plasmodium falciparum: 2nd generation 1,2,4-trioxane-ferrocene hybrids","volume":"97","author":"Reiter","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2016.10.002_bib4","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.ejmech.2015.08.008","article-title":"Novel halogenated 3-deazapurine, 7-deazapurine and alkylated 9-deazapurine derivatives of L-ascorbic or imino-L-ascorbic acid: synthesis, antitumour and antiviral activity evaluations","volume":"102","author":"Stipkovic Babic","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2016.10.002_bib5","first-page":"77","article-title":"Progress in drug research","volume":"vol. 56","year":"2001"},{"key":"10.1016\/j.ejmech.2016.10.002_bib6","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/B978-0-12-405880-4.00004-4","article-title":"Advances in the treatment of varicella-zoster virus infections","volume":"67","author":"Andrei","year":"2013","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.ejmech.2016.10.002_bib7","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/00002030-199006000-00014","article-title":"Emergence of acyclovir-resistant varicella zoster virus in an AIDS patient on prolonged acyclovir therapy","volume":"4","author":"Linnemann","year":"1990","journal-title":"AIDS"},{"key":"10.1016\/j.ejmech.2016.10.002_bib8","doi-asserted-by":"crossref","first-page":"187","DOI":"10.7326\/0003-4819-112-3-187","article-title":"Acyclovir-resistant varicella zoster virus infection after chronic oral acyclovir therapy in patients with the acquired immunodeficiency syndrome (AIDS)","volume":"112","author":"Jacobson","year":"1990","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ejmech.2016.10.002_bib9","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3851\/IMP1472","article-title":"FV-100: the most potent and selective anti-varicella zoster virus agent reported to data","volume":"20","author":"Migliore","year":"2009","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.ejmech.2016.10.002_bib10","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0166-3542(01)00208-X","article-title":"Broad-spectrum antiviral activity of PNU-183792, a 4-oxo-dihydroquinoline, against human and animal herpesviruses","volume":"54","author":"Brideau","year":"2002","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2016.10.002_bib11","doi-asserted-by":"crossref","first-page":"7209","DOI":"10.1016\/j.bmc.2007.03.061","article-title":"Influence of 6 or 8-substitution on the antiviral activity of 3-phenethylthiomethylimidazo[1,2-a]pyridine against human cytomegalovirus (HCMV) and varicella-zoster virus (VZV)","volume":"15","author":"V\u00e9ron","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2016.10.002_bib12","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1016\/j.bmcl.2007.03.102","article-title":"2-Aryl-2-hydroxyethylamine substituted 4-oxo-4,7-dihydrothieno[2,3-b]pyridines as broad-spectrum inhibitors of human herpesvirus polymerases","volume":"17","author":"Schnute","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2016.10.002_bib13","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1016\/j.bmcl.2010.03.115","article-title":"Modifications of C-2 on the pyrroloquinoline template aimed at the development of potent herpesvirus antivirals with improved aqueous solubility","volume":"20","author":"Nieman","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2016.10.002_bib14","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1021\/jm070210n","article-title":"Synthesis and antiviral evaluation of 6-(Alkyl-heteroaryl)furo[2,3-d]pyrimidin-2(3H)-one nucleosides and analogues with ethynyl, ethenyl, and ethyl spacers at C6 of the furopyrimidine core","volume":"50","author":"Robins","year":"2007","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2016.10.002_bib15","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1021\/jm050867d","article-title":"Synthesis and biological evaluation of 6-(Alkyn-1-yl)furo[2,3-d]pyrimidin-2(3H)-one base and nucleoside derivatives","volume":"49","author":"Robins","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2016.10.002_bib16","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0166-3542(01)00208-X","article-title":"Broad-spectrum antiviral activity of PNU-183792, a 4-oxo-dihydroquinoline, against human and animal herpesviruses","volume":"54","author":"Brideau","year":"2002","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2016.10.002_bib17","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1093\/jac\/dkq198","article-title":"ASP2151, a novel helicase-primase inhibitor, possesses antiviral activity against varicellazoster virus and herpes simplex virus types 1 and 2","volume":"65","author":"Chono","year":"2010","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2016.10.002_bib18","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1086\/520094","article-title":"Tumor necrosis factor-\u03b1 and interleukin-1\u03b2 play a critical role in the resistance against lethal herpes simplex virus encephalitis","volume":"196","author":"Sergerie","year":"2007","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.ejmech.2016.10.002_bib19","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ejmech.2014.10.084","article-title":"Synthetic approaches, functionalization and therapeutic potential of quinazoline and quinazolinone skeletons: the advances continue","volume":"90","author":"Khan","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2016.10.002_bib20","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.bmc.2012.12.027","article-title":"N1,N3-disubstituted uracils as nonnucleoside inhibitors of HIV-1 reverse transcriptase","volume":"21","author":"Novikov","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2016.10.002_bib21","doi-asserted-by":"crossref","first-page":"10314","DOI":"10.1021\/jm500902x","article-title":"Optimization of potent and selective quinazolinediones: inhibitors of respiratory syncytial virus that block RNA-dependent RNAPolymerase complex activity","volume":"57","author":"Matharu","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2016.10.002_bib22","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.ejmech.2013.10.057","article-title":"The synthesis, antiviral, cytostatic and cytotoxic evaluation of a new series of acyclonucleotide analogues with a 1,2,3-triazole linker","volume":"70","author":"G\u0142owacka","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2016.10.002_bib23","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1016\/j.bmc.2014.05.020","article-title":"Design, synthesis, antiviral and cytostatic activity of \u0277-(1H-1,2,3-triazol-1-yl)(polyhydroxy)alkylphosphonates as acyclic nucleotide analogues","volume":"22","author":"G\u0142owacka","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2016.10.002_bib24","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1016\/j.bmc.2010.03.024","article-title":"Allosteric inhibitors of hepatitis C virus NS5B polymerase thumb domain site II: structure-based design and synthesis of new templates","volume":"18","author":"Malancona","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2016.10.002_bib25","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/ardp.201300382","article-title":"Design, synthesis, antiviral and cytostatic evaluation of novel isoxazolidine analogues of homonucleotides","volume":"347","author":"\u0141ysakowska","year":"2014","journal-title":"Arch. Pharm. Chem. Life Sci."},{"key":"10.1016\/j.ejmech.2016.10.002_bib26","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF00810042","article-title":"Chinazolincarbons\u00e4uren, 10. Mitt. Synthese von 1-Methyl-2,4-dioxo-chinazolin-3-yl-essigs\u00e4ure, 2,4-Dioxo-chinazolin-1-yl-essigs\u00e4uren, 2,4-Dioxo-1,3-chinazolindiessigs\u00e4uren und deren Estern","volume":"118","author":"S\u00fcsse","year":"1987","journal-title":"Monatsh. Chem."},{"key":"10.1016\/j.ejmech.2016.10.002_bib27","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1080\/00397911.2016.1177087","article-title":"Utilization of isatoic anhydride in the syntheses of various types of quinazoline and quinazolinone derivatives","volume":"46","author":"Abbas","year":"2016","journal-title":"Synth. Commun."},{"key":"10.1016\/j.ejmech.2016.10.002_bib28","doi-asserted-by":"crossref","first-page":"5363","DOI":"10.1016\/j.tetlet.2006.05.104","article-title":"N-Substituted C-diethoxyphosphorylated nitrones as useful synthons for the synthesis of \u03b1-aminophosphonates","volume":"47","author":"Piotrowska","year":"2006","journal-title":"Tetrahedron Lett."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523416308649?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523416308649?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T17:44:55Z","timestamp":1565372695000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523416308649"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":28,"alternative-id":["S0223523416308649"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2016.10.002","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis, anti-varicella-zoster virus and anti-cytomegalovirus activity of quinazoline-2,4-diones containing isoxazolidine and phosphonate substructures","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2016.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}